Neuromodulation Intervention in Resistant Depression

Neuromodulation for treatment-resistant depression

Treatment-resistant depression affects at least 1-3% of the US population. This article reviews the current state of focal neuromodulation therapies for treatment-resistant depression, focusing on those treatments published clinical data. These include transcranial magnetic stimulation, transcranial direct current stimulation, magnetic seizure therapy, vagus nerve stimulation, direct cortical s...

CORRIGENDUM TO: Neuromodulation for treatment-resistant depression

permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes.

Neuromodulation therapies and treatment-resistant depression

BACKGROUND Patients with treatment-resistant depression (TRD) who showed partial response to pharmacological and psychotherapeutic interventions need a trial of neuromodulation therapies (NTs). OBJECTIVE This paper aims to review evidence-based data on the use of NTs in TRD. METHOD Using keywords and combined-word strategy, multiple computer searches of PubMed, Google Scholar, Quertle(R), a...

Update on Neuromodulation for Treatment-Resistant Depression

About 30% of patients suffering from a major depressive disorder do not respond sufficiently to established pharmacological, psychotherapeutic, or somatic treatments. Advances in technology and emerging knowledge about the dysfunctional brain circuits underlying depression have led to the development of different neuromodulation techniques. The aim of the present review is to give an update on ...

Neuromodulation durch Vagusnervstimulation bei Depression